Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 1/20 | 0.57 |
| ▸ | GCGR | P47871 | 1/20 | 0.57 |
| ▸ | GIPR | P48546 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 3/20 | 0.56 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.56 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.56 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.55 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.53 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.52 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.51 |
| ▸ | TFPI | P10646 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30428639 | 0.95 | BACE1 (0.56) | GLP1RGCGRGIPRBACE1BACE2 | |
| SCHEMBL30648478 | 0.95 | GLP1R (0.57) | GLP1RGCGRGIPRBACE1BACE2 | |
| SCHEMBL31182625 | 0.93 | BACE1 (0.57) | GLP1RGCGRGIPRBACE1BACE2 | |
| SCHEMBL38664549 | 0.93 | GLP1R (0.52) | GLP1RGCGRGIPRBACE1VIPR1 | |
| SCHEMBL30880910 | 0.92 | BACE1 (0.55) | GLP1RGCGRGIPRBACE1BACE2 | |
| SCHEMBL30880889 | 0.91 | BACE1 (0.54) | GLP1RGCGRGIPRBACE1BACE2 | |
| SCHEMBL31182595 | 0.91 | GLP1R (0.68) | GLP1RGCGRGIPRVIPR1VIPR2 | |
| SCHEMBL30320569 | 0.91 | BACE1 (0.58) | BACE1BACE2VIPR1VIPR2KISS1R | |
| SCHEMBL31182459 | 0.91 | GLP1R (0.56) | GLP1RGCGRGIPRBACE1BACE2 | |
| SCHEMBL31182935 | 0.90 | TFPI (0.62) | GLP1RGCGRGIPRBACE1VIPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283037-A1 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2025-09-11 | — | — | US | disclosed |